Previous 10 | Next 10 |
SALT LAKE CITY, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and full year 2022 operating results on Tuesday, February 28, 20...
Summary There are several underlying growth drivers further driving the adoption for HCAT solutions. HCAT differentiated product offering, strong M&A track record, and ability to further penetrate existing base of users are what drive top line growth. The better-than-expected pr...
Health Catalyst Announces a New, External Leadership Assignment for Paul Horstmeier PR Newswire SALT LAKE CITY , Jan. 6, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services...
Tech stocks had as difficult a year as any sector in 2022, with the Nasdaq-100 tech index falling more than 39% over the past year. It's hard to find tech stocks , which are known for their growth, that weren't hit by falling share prices. Health Catalyst (NASDAQ: HCAT) ,...
Summary Health Catalyst, Inc., after a 74% downside, spells opportunity, especially when ratings are all favorable. However, analysts at Evercore think differently and have downgraded Health Catalyst stock. After assessing opportunities and risks, I conclude that Health Catalyst sto...
Health Catalyst ( NASDAQ: HCAT ), a vendor of software solutions to healthcare establishments, dropped Tuesday after Evercore ISI downgraded its shares to In-Line from Outperform, citing a challenging setup for health systems, including hospitals. “While it is not new that hosp...
Carle Health Partners with Health Catalyst to Achieve Data-Informed Improvement PR Newswire SALT LAKE CITY , Dec. 5, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to ...
Shares of Health Catalyst (NASDAQ: HCAT) , jumped 23.34% on Wednesday. The stock closed on Tuesday at $6.47, then opened on Wednesday at $8.54. It ran as high as $8.59 before closing at $7.98. So far this year, the stock is still down more than 79%. It has a 52-week low of $6.40 and...
Health Catalyst ( NASDAQ: HCAT ) stock rose ~23% on Wednesday after Q3 results beat estimates and the company raised its FY22 outlook which was seen above consensus. Total revenue grew +10.72% Y/Y to $68.35M. Technology revenue increased +15% Y/Y to ~$44M, wh...
Health Catalyst, Inc. (HCAT) Q3 2022 Earnings Conference Call November 08, 2022, 05:00 PM ET Company Participants Adam Brown - Senior Vice President-Finance and Investor Relations Daniel Burton - Chief Executive Officer Bryan Hunt - Chief Financial Officer ...
News, Short Squeeze, Breakout and More Instantly...
Health Catalyst Announces New Credit Facility for up to $225,000,000 PR Newswire SALT LAKE CITY , July 18, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company") (Nasdaq: HCAT), a leading provider of data and analytics technology and...
2024-07-01 07:30:03 ET Wells Fargo analyst issues OVERWEIGHT recommendation for HCAT on July 1, 2024 06:12AM ET. The previous analyst recommendation was Overweight. HCAT was trading at $6.39 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...